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Introduction: The risk of tuberculosis (TB) in healthcare personnel (HCP) is related to its incidence in the general
population. Healthcare students involved in clinical training could be exposed to occupational risks similar to those
that HCP face. The prevalence of latent tuberculosis infection (LTBI) among undergraduate healthcare students with
different working seniority in Italy was analysed.
Methods: A cross-sectional study under a screening programme for LTBI among undergraduate and postgraduate
students attending Medical School at the Second University of Naples was conducted between January 2012 and
December 2013 with clinical evaluations, tuberculin skin testing (TST) and, in positive TST students, Interferon-γ
release assays (IGRA). Putative risk factors for LTBI were assessed by means of a standardised questionnaire.
Results: 3,374 students attending the Medical School of the Second University of Naples were submitted to a
screening programme for TBC. 3,331 performed TST as a first-level test and 43 performed a Quantiferon test (QFT).
128 students were TST-positive and continued the diagnostic work with QFT, which was positive in 34 students. Of
the 43 subjects who took the QFT as a first-level test only 1 was positive. In 35 students positive to the QFT test
we formulated the diagnosis of LTBI by clinical and radiographic results. A correlation was found between age,
non-Italian born persons, studying age, post-medical school status and LTBI.
Conclusions: The prevalence of LTBI among healthcare students in our study was very low. In countries with a low
incidence of TB, the screening programmes of healthcare students can be useful for early identification and
treatment of sporadic cases of LTBI.
Keywords: Medical students, Tuberculosis, Tuberculin skin testing, Quantiferon test, Health surveillance,
Occupational exposureIntroduction
According to the World Health Organization (WHO),
there were an estimated 8.6 million cases of tuberculosis
(TB) (range 8.3–9.0 million) globally in 2012, equiva-
lent to 122 cases per 100,000 people. One third of the
world’s population is estimated to be latently infected
with Mycobacterium tuberculosis. People with latent TBC
infection (LTBI) do not show symptoms of TB and are
not infectious, but they are at risk of developing active* Correspondence: monica.lamberti@unina2.it
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unless otherwise stated.disease and becoming infectious in about 10% of cases in
the course of their lives. In around half of these cases, ac-
tive TB develops within the first two years after infection.
[1]. Malnutrition, homelessness and alcoholism, along
with HIV infection and other diseases that weaken the im-
mune system, or immunosuppressive therapies (in which
TNF-alpha blockers are especially significant) are typical
risk factors for activation of LTBI [2].
TB is a current risk even in low-income countries due
to abandonment of vaccination campaigns, immigration
flows, wide diffusion of primary or secondary immuno-
suppression and poor efficacy of vaccines currently inal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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problem for public health.
The overall incidence of TB in Italy in recent years
was 7.85 per 100,000 with approximately 4,400 new TB
cases annually. In the past decade there has been a pro-
gressive decrease in its incidence in people aged over
60 and a slight and gradual increase in age groups
from 15 to 64. [5] In healthcare personnel (HCP), the
risk of TB infection is increased by exposure to pa-
tients with infectious disease, insufficient use of protective
equipment such as respirators, and working conditions,
particularly in inadequately ventilated areas and when
conducting techniques that involve exposure to contami-
nated aerosols [6,7].
Healthcare students involved in clinical training could
be exposed to occupational risks similar to those of
HCP. In fact, the annual risk of TB infection (ARTI)
among medical and nursing trainees was found to be 5%
in countries with a high incidence of TB, 3 times higher
than the 1.5% ARTI estimate for the general public. [8]
LTBI screening of both healthcare workers and under-
graduate students is recommended in low-incidence
countries regardless whether or not there is knowledge
of transmission, prevention, and diagnosis [9] in order to
obtain an early diagnosis of cases and prevent progres-
sion to active disease. The main purpose of this study
was to evaluate the prevalence of LTBI among under-
graduate healthcare students, in a context of low endem-
icity such as Italy’s, and it found possible associations
between the outcome of the screening tests and epi-
demiological variables.
Material and method
From January 2012 a screening programme for TB was
approved and carried out at the Second University of
Naples, which can be classified as a “low-risk” institution
according to the CDC guidelines [10]. According to this
programme all students in their first, third and sixth
year of medical school, students at health profession
school in their first and third year and students of spe-
cialised schools in their first and third year are actively
required to undergo TB screening. The students of the
health profession school are nursing students, paediatric
nursing students, student radiographers and midwifery
students; the students of specialised schools are post-
medical school students. All the individuals evaluated in
this programme between January 2012 and December
2013 were enrolled in this cross-sectional study. For each
individual, information on the following variables was col-
lected using a standardised questionnaire: age, gender,
time of study in healthcare setting (study age), previous
exposure to TB, family history of TB, BCG vaccination,
place of birth, prior TST, workplace and chest radiogra-
phic findings. BCG vaccination was verified by scars orvaccination records. Tuberculin Skin Test (TST) was
performed by trained personnel following standard proce-
dures. In brief, 0.1 mL (2 TU) of purified protein deriva-
tive (PPD, RT23; Statens Serum Institute, Copenhagen,
Denmark) was injected. The TST was administered to the
volar side of the forearm of the participants and read 72
to 96 hours after application. A positive TST was defined
as an induration measuring ≥ 10 mm in healthy sub-
jects [11]. The transverse diameter of the induration was
measured by specialised personnel. All the TST-positive
cases were also tested with an Interferon-Gamma Release
Assay (IGRA; QuantiFERON® TB-Gold Cellestis, Carnegie,
Australia) to confirm the diagnosis of LTBI because of
its major specificity compared with conventional TST
[12]. The subjects with positivity for TST and Quantiferon
(QFT) test, were in the absence of clinical and radio-
graphic signs of active tuberculosis considered to have
an LTBI. The blood samples were treated as recommen-
ded by the manufacturer. Briefly, 1 ml of whole blood
was sampled in each of the three QFT tubes containing
either TB-specific antigen (ESAT-6, CFP-10 and TB7.7),
no antigen (negative control) or mitogen antigen (positive
control), tubes were incubated at 37°C overnight before
centrifugation, and IFN-γ concentrations (IU/ml) were
measured by ELISA following the manufacturer’s protocol.
An IFN-γ ≥ 0.35 IU/ml (TB antigens minus negative con-
trol) was considered a positive test [13]. All the IGRA
positive cases were carefully examined by an infectious
diseases specialist and underwent chest radiography.
Individuals with a history of allergy, secondary im-
munodeficiency or pregnancy were offered the oppor-
tunity to take the QFT as a first-level examination. In
fact, although in literature there is no evidence that ad-
verse reactions to the Mantoux test can influence the
course of pregnancy [14], in order to enhance the pro-
tection of pregnant students,QFT was used as examin-
ation of the first level to reduce the risk of allergic type
reactions to TST and to avoid the pregnant woman
having to undergo two diagnostic tests in case of TST
positivity.
Furthermore, IGRAs may be more sensitive than TST
in immunosuppressed individuals and those less affected
by advanced immunosuppression [15]. Statistical analysis
of data was performed using SPSS v.17.0 software. Con-
tinuous variables were summarised as mean and stand-
ard deviation and categorical variables as absolute and
relative frequencies. Differences in the mean were evalu-
ated by an unpaired Student t-test, and the Chi-squared
test was applied to categorical variables. A p value of <0.05
was considered to be statistically significant.
All activities were performed in compliance with the
Helsinki Declaration and current healthcare standards ac-
cording to the recommendations of the Italian Ministry of
Health [16]. All students included in the survey were
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the survey and written informed consent was obtained.
According to Italian legislation on the guidelines for ob-
servational studies, ethical approval for conducting this
survey was unnecessary and on this basis cross-sectional
studies did not require formal approval by local Institu-
tional Review Boards [17]. Personal information on the
subjects included in the study was protected according to
Italian law [18].
Results
All 3,374 subjects, students attending the medical school,
those attending the health profession school and specia-
lised doctors at the Second University of Naples evaluated
in the TB screening programme from January 1, 2012 to
December 31, 2013 were included in the study. The main
demographic and epidemiological characteristics of all
subjects enrolled are listed in Additional file 1: Table S1.
All subjects reported that they had no previous contact
with a confirmed TB disease case. A history of a pre-
vious TST negative test and subsequently BCG vaccin-
ation was identified in 125 older subjects (mean age 29.7
(+3.7) years) included in the study, 82 females and 43Figure 1 Study flow chart. TST Tuberculin Skin Test; QFT QuantiFERON®males. They were vaccinated as required by the previous
italian DPR. n.465/2001 , then abrogated.
Of the 3,374 subjects enrolled, 3,331 underwent TST
as a first-level examination and 43 QFT (Figure 1). Of
these 43, 22 had a positive history of drug allergy, 17
were pregnant and 4 were treated with immunosuppres-
sive drugs. Of the 3,331 subjects who performed TST as
a first test, 128 (3.8%) were positive, 3,160 (94.9%) nega-
tive and 43 (1.3%) were absent for reading in the window
period from 72 to 96 hours after intradermal injection
(20 women, 23 men, all Italian students). In these sub-
jects we required to repeat the TST test after a month: it
happened in 36 with negativity for TST, while the re-
maining 7 renounced to attend university and therefore
have not performed a new test.
Regarding the safety profile of the tuberculin test, none
of the individuals who took the test showed loco-regional
or systemic allergic adverse reactions. Induration by TST
ranged between 0 e 40 mm (Figure 2). All individuals with
positive TST continued the diagnostic work-up by taking a
QFT with the following results: 34 (26.5%) were positive
and 94 (73.5%) negative. No significant correlation was
observed between the size of TST induration and QFTTB-Gold Test; LTBI latent tuberculosis infection.
Figure 2 Distribution of tuberculin skin test reactions (induration in mm).
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tive for QFT, 22 (23.4% of cases) had a history of BCG
vaccination.
Of the 43 individuals who took QFT as first test, only
one was positive. She was a pregnant medical specialist.
She did not continue the diagnostic work-up with the
diagnostic radiological techniques in accordance with the
respiratory specialist and was included in a clinic dedi-
cated follow-up programme. The 34 individuals tested
positive for TST and QFT performed pulmonary consult-
ation and chest X-ray. Clinical and radiographic signs of
active tuberculosis were ruled out for all. Thus LTBI was
identified in 35 of the 3,331 individuals tested (1.05%).
Everyone was given an indication to undergo chemopro-
phylaxis. Only 8 students adhered to the drug treatment,
and follow-up. Others 27 students refused a isoniazid pre-
ventive therapy (IPT).
Additional file 2: Table S2 shows the demographic
characteristics of the 35 students with LTBI and the 3,253
without. Students with LTBI were older (31 + 6.3 years vs
25.5 + 5, p < 0.000), more frequently non-Italian born
(8.6% vs. 0.5%, p < 0.000) and had a higher studying age
3.4 + 2.5 years vs 2.05 + 2.1, p < 0.000). A history of BCG
vaccination was present (3.8% of cases) only in the group
without LTBI. Instead, the individuals with LTBI were
more frequently composed of students at postgraduate
medical schools (42.9% vs. 25.6%, p < 0.05).
Discussion
There is growing awareness of the problem of nosoco-
mial TB and the need to protect healthcare workers in
the era of multidrug-resistance (MDR) [19]. However,studies in industrialised countries have shown annual
TST conversion rates ranging from 0.1% to 2% among
unexposed personnel and from 0.5% to 14% among
highly exposed HCP [20]. Programs for the screening
and treatment of LTBI cases within HCP, combined
with other interventions aimed at reducing the risk of
nosocomial transmission, represent fundamental tools
of TB control programmes and are strongly recommen-
ded in many countries with low TB incidence, including
Italy [9,21].
The likelihood of developing active TB during the first
two years following a positive IGRA is significantly lower
for healthcare workers than for close contacts in the
general population. This can probably be explained by
the fact that healthcare workers have a low incidence of
risk factors for developing active TB such as for example
alcoholism, homelessness and that a positive IGRA in
healthcare workers is often caused by an remote LTBI
with a low risk of progression [3].
Students and assistants in training are considered po-
tentially exposed to hospital infections as HCP [22]. Stud-
ies performed in high-incidence countries have reported
LTBI prevalence figures ranging from 9.2% to 72% among
healthcare students [23-26]. Our findings showed a pre-
valence of TST positive cases among all subjects of only
3.9%. Moreover, the diagnosis was confirmed by IGRA
testing in only 35 students. Thus the prevalence of LTBI
in this cohort was 1.05%. These results tally with the data
observed among healthcare students at the beginning of
the training period in various occupations (nurses, med-
ical students, physiotherapists) by other authors in Europe
[27-29] and are justified by the low risk of contact with
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ease in industrialised countries.
Therefore, based on our data and in view of the low
incidence of positive TST students, a risk evaluation
every two or three years in absence of a new exposure
appears to be sufficient to ensure workers’ health. How-
ever, a specific study on the periodicity of risk evaluation
seams to need to clarify this point.
A higher age and studying age, to be non-Italian born
and a postgraduate student at medical school seem to be
factors associated with LTBI.
The role of age in influencing the TST positivity risk is
controversial. Some studies revealed a significant posi-
tive association between age and TST conversion, [30,31]
whereas others did not confirm this association [32,33]. In
this study, the association between LTBI and a higher age,
studying age and being a postgraduate student at medical
school seems to suggest a higher risk of TB exposure in
students with a longer stay in healthcare settings.
The higher prevalence of LTBI in non-Italian students
reflected the epidemiology of TB. In our sample, the per-
centage of latent forms among foreigners was 14% ver-
sus 1% in the Italian group. All overseas students with
LTBI come from countries where TB is endemic (Brazil,
Ecuador, Eritrea, Mexico, Moldova, Russia, Ukraine). As
shown in literature [34,35], the prevalence and incidence
of tuberculosis in the country of origin can affect the
outcome of the screening test. In countries with high en-
demicity that are often those with higher immunization
coverage, we expected a high rate of positive skin test re-
sults, so that for workers from these countries the perform-
ance of QFT as a first-level test may be taken into account.
Considering the 93 subjects with positivity for TST
and negativity for QFT, 21 had a history of BCG vaccin-
ation, while in the others 72 a possible cause of the po-
sitive TST test could be contact with non-tuberculous
mycobacteria [36].
The tuberculin skin test in our experience is safe and
widely used (no case of loco-regional or systemic allergic
reactions) and the use of IGRA in TST-positive students
reduces the potential occurrence of “false positive” cases
due to exposure to atypical mycobacteria or BCG vac-
cination. However, both the TST and IGRA tests have
limitations in diagnosing LTBI. The main problems with
TST depend on technical limitations, difficulty in inter-
preting the results and the existence of a significant num-
ber of false positives [37,38]. On the other hand, IGRA
tests, despite being more specific and having at least iden-
tical sensitivity to TST [39-41], present difficulties in inter-
preting results near the cut-off between positive/negative
and also have higher unit costs [42]. Therefore our choice
of using IGRA test as second-level examination in positive
TST students was aimed at optimising costs and increas-
ing the level of diagnostic accuracy.Conclusion
In this study we evaluated the incidence of TB in classes
of healthcare students and postgraduate students at
medical school with different studying ages. We confirm
a low prevalence of LTBI among undergraduate and post-
graduate healthcare students in our region. So in countries
with a low incidence of TBC such as Italy a LTBI two-step
screening strategy for healthcare students before and dur-
ing clinical training seems justified [43].
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